Atara Biotherapeutics, Inc. , an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States.
Atara Biotherapeutics stock last closed at $7.11, up 1.28% from the previous day, and has decreased 58.35% in one year. It has overperformed other stocks in the Biotechnology industry by 0.22 percentage points. Atara Biotherapeutics stock is currently +31.67% from its 52-week low of $5.40, and -65.84% from its 52-week high of $20.81.
As of Mar 19, 2025, there are 5.86M ATRA shares outstanding. The market cap of ATRA is $41.66M. In the past 24 hours, 91,251 ATRA shares were traded.
How to Buy Atara Biotherapeutics Stock
Wondering how to invest in Atara Biotherapeutics stock? Here's how.
Figure out where to buy Atara Biotherapeutics stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Atara Biotherapeutics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Choose your payment method and add your details.
Analyze Atara Biotherapeutics stock: The Atara Biotherapeutics ticker symbol is ATRA. Is Atara Biotherapeutics stock a good investment? Should you buy shares of ATRA? How do ATRA's underlying business fundamentals look? Do top analysts think Atara Biotherapeutics is a good buy? Why has ATRA's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if ATRA is a good stock to buy).
Place your ATRA buy order: Decide if you will purchase ATRA shares at the current market price or use a limit order to purchase ATRA shares at a given price.
Get updates on your ATRA position: Create a watchlist to key updates about your position in Atara Biotherapeutics stock.
Step 1: Figure out where to buy Atara Biotherapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy ATRA stock.
A brokerage account enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you can buy ATRA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Atara Biotherapeutics stock
After you have chosen the best place to buy Atara Biotherapeutics stock, it's critical to evaluate their stock before you invest, so you can comprehend the risk as well as the upside.
Atara Biotherapeutics stock data
ATRA Price
$7.11
1w %
3.19%
1y %
-58.35%
5y %
-96.44%
P/E
-0.62x
P/B
-0.43x
P/S
0.41x
PEG
N/A
Revenue
$128.94M
Earnings
-$85.40M
Fore. Rev. Growth
-31.47%
Fore. Earn. Growth
N/A
Market Cap
$41.66M
Next Earnings
Mar 26, 2025
Next Dividend
N/A
Atara Biotherapeutics Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
Last year, ATRA revenue was $128.94M. In the last three year, ATRA's revenue has increased by 174.78% per year. This was faster than the Biotechnology industry average of 45.43%.
No, Atara Biotherapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about ATRA?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your ATRA buy order
You have two main types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and your broker will place your order.
If you need additional assistance investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Atara Biotherapeutics share?
As of Mar 19, 2025, it costs $7.11 to buy one share of Atara Biotherapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.422 shares of ATRA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.